Naomi Fried

PharmStars founders Naomi Fried and Laura Gunn
By  Laura Lovett 01:20 pm June 1, 2021
The pharma world is notoriously slow moving, taking years to develop a molecule. Meanwhile digital health companies are often working at breakneck speed to innovate. This is just one of the many culture gaps the pair encounter working together, according to digital innovation vet Naomi Fried. This morning, Fried and pharmaceutical exec Laura Gunn announced a new accelerator, dubbed PharmStars, ...
Researcher
By  Naomi Fried and Laura Gunn 10:55 am May 25, 2021
Digital health has the potential to transform the pharmaceutical industry and the patient experience. Both digital health startups and pharma are eager to engage each other. Pharma continues to have significant need to leverage innovative "beyond the pill solutions."  Digital health startups offer a wealth of potential solutions, and investors have noticed. Such startups attracted over $6.7...
By  Naomi Fried 01:47 pm January 28, 2020
Update: HIMSS20 has been canceled due to the coronavirus. Read more here. About the author: Naomi Fried, PhD, is the CEO of Health Innovation Strategies, which provides digital health strategy and innovation-program design and optimization consulting to healthcare stakeholders including pharma, payers and providers. Her previous positions include the first chief innovation officer at Boston...
By  Naomi Fried 10:32 am February 21, 2018
About the author: Naomi Fried, PhD, is the CEO of Health Innovation Strategies, which provides digital health strategy and innovation-program design and optimization consulting to healthcare stakeholders including pharma, payers, and providers. Her previous positions include the first Chief Innovation Officer at Boston Children’s Hospital, Biogen’s VP of Innovation and External Partnerships, and...
By  Naomi Fried 11:47 am February 10, 2017
About the author: Naomi Fried, PhD (@NaomiFried), is the CEO of Health Innovation Strategies, which provides digital health strategy and innovation infrastructure consulting to healthcare stakeholders including pharma companies and providers. Her previous positions include the first Chief Innovation Officer at Boston Children’s Hospital, Biogen’s VP of Innovation and External Partnerships, and VP...
By  Jonah Comstock 07:24 am June 15, 2015
Boston Children's Hospital has tapped John Brownstein, currently the director of the hospital's computational epidemiology group, as its new Chief Innovation Officer. Brownstein will succeed Naomi Fried, who left the company at the end of December to become Vice President of Medical Information, Innovation, and External Partnerships at Biogen Idec. "John Brownstein, PhD, was the top management...
By  Aditi Pai 05:48 am January 28, 2015
Biogen Idec used Fitbit bands in a previous study Biogen Idec has partnered with Google X, Google's business unit for long-term “moonshot” projects, to study outside factors that might contribute to the progression of multiple sclerosis (MS), according to a report from Bloomberg. Google and Biogen will use sensors, software, and data analysis tools to collect and analyze data from people who...
By  Jonah Comstock 04:37 am December 8, 2014
Naomi Fried, Boston Children’s Hospital’s Chief Innovation Officer, is leaving the hospital to become Vice President of Medical Information, Innovation, and External Partnerships at Biogen Idec, MobiHealthNews has learned. "I have loved working at Boston Children’s, which is one of the finest organizations in the world," she wrote in an email. "I feel grateful to all of the people at Boston...
By  Aditi Pai 08:15 am December 4, 2014
Providers are using a lot of health technology, but they aren't using enough technology to interact with patients, Boston Children's Hospital CIO Naomi Fried said at a MassTLC healthcare conference in Boston this week. "There’s a continuum when you think about digital...pure digital vs. pure patient-doctor interaction," Fried said. "I think where we are on the spectrum right now is way too...